23948sdkhjf
  • {{ window.visitor.corporateClient.name }}
    Corporate solution
    {{ window.visitor.ipAccess.corporateClient.name }}
    {{ window.visitor.corporateClient.name }}

  • Welcome to our Corporate client solution

    Here you can administrate your corporate solutions users.

  • Welcome to your subscription for Life Science Focus

  • Welcome to our Corporate client solution

    Your IP is registered with the company mentioned above and provides access to Life Science Focus.

  • Click here to go to sign-up
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Try Life Science Focus now
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement
Medtech

Abbott sharpens cancer test – detects smaller traces of tumour DNA

A single tumour DNA molecule among more than a million others. That is how small a trace of cancer Abbott’s upgraded Oncodetect test is designed to detect in the blood. The technology has now also demonstrated improved performance in clinical studies.
Advertisement

Detecting traces of cancer in the blood after treatment is a challenge, particularly when the amount of tumour DNA is very small.

Abbott has now launched a more sensitive version of its Oncodetect test, designed to give doctors better tools to assess the risk of recurrence, according to a press release from the company.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.062|